Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyrotoxicosis in the critically ill.

C A Reasner1, W L Isley

  • 1Division of Endocrinology and Metabolism, University Texas Health Science Center, San Antonio.

Critical Care Clinics
|January 1, 1991
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

No, the glycaemic target in the critically ill should not be < or = 6.1 mmol/l.

Diabetologia·2007
Same author

Hepatotoxicity of thiazolidinediones.

Diabetes, obesity & metabolism·2002
Same author

Use of cold iodine in patients with Graves' disease: observations from a clinical practice.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·2001
Same author

Glitazones, glycemia, and global health status.

Diabetes care·2001
Same author

Treatment of type 2 diabetes mellitus: a rational approach based on its pathophysiology.

American family physician·2001
Same author

Clinical trial evidence for the cardioprotective effects of omega-3 fatty acids.

Current atherosclerosis reports·2001
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Thyrotoxicosis can mimic cardiac issues, posing a diagnostic challenge in critical care. Early recognition and treatment of this thyroid disorder are crucial for patient outcomes.

Area of Science:

  • Critical Care Medicine
  • Endocrinology

Background:

  • Thyrotoxicosis presents diagnostic challenges in critical care settings.
  • Symptoms often overlap with non-thyroidal conditions, particularly cardiac issues.

Observation:

  • Patients may present with tachyarrhythmias, new-onset heart failure, weight loss, or altered mental status.
  • The correct diagnosis is often endocrinological, despite initial presentation suggesting other pathologies.

Findings:

  • Considering thyrotoxicosis is vital for patients with unexplained cardiac symptoms or metabolic changes.
  • Treatment initiation may precede definitive diagnostic test results.

Implications:

  • Prompt diagnosis and management of thyrotoxicosis are essential for successful critical care outcomes.

Related Experiment Videos

  • Awareness of thyrotoxicosis as a differential diagnosis improves patient care in complex cases.